Discover the LATISSE® difference.
LATISSE® solution is a growth treatment for lashes. In fact, it’s the only FDA-approved treatment clinically proven to grow lashes. And it’s the only lash growth product of its kind available by prescription. So you’ll need to talk to your doctor to see if it’s right for you.
LATISSE® grows lashes longer, fuller and darker.
LATISSE® solution is a once-nightly treatment you apply topically to the base of your upper eyelashes, as instructed by your doctor. Then, gradually, the results come in. You may start to see more length in as little as 4 weeks and you should achieve full growth in 16 weeks. It’s not an illusion of growth. It’s real lash growth.
How LATISSE® works.
LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.
The history behind LATISSE®.
LATISSE® was created by Allergan, a pharmaceutical leader with 60 years of eye care expertise. In 2001, Allergan developed a medicated eye drop to treat elevated intraocular pressure. Many patients using this medication also began to grow longer, fuller and darker lashes as a side effect. This led Allergan to study the medication’s active ingredient, bimatoprost, specifically for growing lashes. After a clinical trial, LATISSE® was approved by the FDA in December of 2008.
Results at a Glance
These pictures illustrate the real lash-growth benefit of LATISSE® — the first and only FDA-approved prescription treatment for inadequate or not enough lashes, growing them longer, fuller and darker. Users may star t to see longer lashes at week 4, with full growth by week 16. Ask your doctor if LATISSE® is right for you. By prescription only. Please see Important Safety Information below.
You may be surprised to know that medical journals have linked thinning and loss of eyelashes to aging.
When Allergan analyzed the photos of a subset of women with inadequate or not enough lashes from the LATISSE® clinical trials, they noticed that the older women had thinner, shorter and lighter lashes at week 0, compared to the younger women in the trial. The demographic data suggests there may be a downward trend of eyelash fullness, length and darkness as women with inadequate lashes age.
Take a moment to assess your lashes.
Perhaps you’ve noticed a change in your lashes over the years. Have they lost their fullness? Do they appear shorter? Or lighter in color? If so, it’s time to consider LATISSE® — the only FDA-approved product that grows lashes, increasing their overall prominence. Then, ask your doctor if it’s right for you.
LATISSE® can grow thinning lashes.
Xing the Phase III LATISSE® clinical trial, 91% of women participating (n=134) were 35 or older2 and results show that LATISSE® more than doubled their lash fullness after 16 weeks of treatment. If you don’t have enough lashes, incorporating LATISSE® into your treatment regimen may help you grow longer, fuller and darker lashes.